GPC3 and neoplasm: In addition, the three-gene risk-score model (involving MFI2, FOXM1, and GPC3) for LUAD and the two-gene risk-score model (involving SERPINA1 and FOXM1) for LUSC might be useful in predicting the prognosis of tumour patients.